Renin, prorenin and the putative (pro)renin receptor

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 6, Issue 3, 2005, Pages 163-165

  Danser, A H Jan ^a   Deinum, Jaap ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSINOGEN; PRORENIN; PRORENIN RECEPTOR; RECEPTOR; RENIN; RENIN INHIBITOR; SOMATOMEDIN B RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; DIFFUSION; ENZYME ACTIVATION; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME ASSAY; ENZYME BINDING; ENZYME INHIBITION; HUMAN; IMMUNOASSAY; NONHUMAN; PROTEIN DEGRADATION; PROTEIN FOLDING; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE DISTRIBUTION;

HUMANS; RECEPTORS, CELL SURFACE; RENIN; VACUOLAR PROTON-TRANSLOCATING ATPASES;

EID: 33144465031     PISSN: 14703203     EISSN: None     Source Type: Journal    
DOI: 10.3317/jraas.2005.025     Document Type: Article

References (29)

1. Hobart PM, Fogliano M, O'Connor BA, Schaefer IM, Chirgwin JM. Human renin gene: structure and sequence analysis. Proc Natl Acad Sci USA 1984;81:5026-30.
2. Danser AHJ, Derkx FHM, Schalekamp MADH, Hense HW, Riegger GAJ, Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens 1998;16:853-62.
3. Danser AHJ, Deinum J. Renin, Prorenin and the Putative (Pro)renin Receptor. Hypertens 2005;46:1069-76.
4. Lenz T, Sealey JE, Maack T et al. Half-life, hemodynamic, renal, and hormonal effects of prorenin in cynomolgus monkeys. Am J Physiol 1991;260:R804-R810.
5. Derkx FHM, Deinum J, Lipovski M, Verhaar M, Fischli W, Schalekamp, MADH. Nonproteolytic "activation" of prorenin by active site-directed renin inhibitors as demonstrated by renin-specific monoclonal antibody. J Biol Chem 1992;267:22837-42.
6. Pitarresi TM, Rubattu S, Heinrikson R, Sealey JE. Reversible cryoactivation of recombinant human prorenin. J Biol Chem 1992;267:11753-9.
7. Suzuki F, Hayakawa M, Nakagawa T et al. Human prorenin has "gate and handle" regions for its non-proteolytic activation. J Biol Cbem 2003;278:22217-22.
8. Deinum J, Derkx FHM, Schalekamp MADH. Probing epitopes on human prorenin during its proteolytic and non-proteolytic activation. Biochim Biophys Acta 1998; 1388:386-96.
9. Galen FX, Devaux C, Atlas S et al. New monoclonal antibodies directed against human renin. Powerful tools for the investigation of the renin system. J Clin invest 1984; 74:723-35.
10. Deinum J, Derkx FHM, Schalekamp MADH. Improved immunoradiometric assay for plasma renin. Clin Chem 1999;45:847-54.
11. de Bruin RA, Bouhuizen A, Diederich S, Perschel FH, Boomsma F, Deinum J. Validation of a new automated renin assay. Clin Chem 2004;50:2111-16.
12. van Kats JP, Danser AHJ, van Meegen JR, Sassen LM, Verdouw PD, Schalekamp MADH. Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation 1998;98: 73-81.
13. van Kats JP, Schalekamp MADH, Verdouw PD, Duncker DJ, Danser AHJ. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int 2001;60: 2311-17.
14. Danser AHJ, van Kats JP, Admiraal PJJ et al. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 1994;24:37-48.
15. Katz SA, Opsahl JA, Lunzer MM, Forbis LM, Hirsch AT. Effect of bilateral nephrectomy on active renin, angiotensinogen, and renin glycoforms in plasma and myocardium. Hypertension 1997;30:259-66.
16. Hilgers KF, Veelken R, Müller DN et al. Renin uptake by the endothelium mediates vascular angiotensin formation. Hypertension 2001;38:243-8.
17. Kantachuvesiri S, Fleming S, Peters J et al. Controlled hypertension, a transgenic toggle switch reveals differential mechanisms underlying vascular disease. J Biol Chem 2001;276:3672-733.
18. Prescott G, Silversides DW, Reudelhuber TL. Tissue activity of circulating prorenin. Am J Hypertens 2002;15:280-5.
19. van den Eijnden MMED, de Bruin RJA, de Wit E et al. Transendothelial transport of renin-angiotensin system components. J Hypertens 2002;20:2029-37.
20. Campbell DJ, Valentijn AJ. Identification of vascular renin-binding proteins by chemical cross-linking: inhibition of binding of renin by renin inhibitors. J Hypertens 1994;12: 879-90.
21. Müller DN, Fischli W, Clozel JP et al. Local angiotensin II generation in the rat heart: role of renin uptake. Circ Res 1998;82:13-20.
22. Loudon M, Bing RF, Thurston H, Swales JD. Arterial wall uptake of renal renin and blood pressure control. Hypertension 1983;5:629-34.
23. van Kesteren CAM, Danser AHJ, Derkx FHM et al. Mannose 6-phosphate receptor-mediated internalization and activation of prorenin by cardiac cells. Hypertension 1997;30:1389-96.
24. Nguyen G, Delarue F, Burcklé C, Bouzhir L, Gillet T, Sraer J-D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002;109:1417-27.
25. van den Eijnden MMED, Saris JJ, de Bruin RJA et al. Prorenin accumulation and activation in human endothelial cells. Importance of mannose 6-phosphate receptors. Arterioscler Thromb Vasc Biol 2001;21:911-16.
26. Saris JJ, van den Eijnden MMED, Lamers JMJ, Saxena PR, Schalekamp MADH, Danser AHJ. Prorenin-induced myocyte proliferation: no role for intracellular angiotensin II. Hypertension 2002;39:573-7.
27. Nguyen G, Delarue F, Berrou J, Rondeau E, Sraer JD. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 1996;50:1897-903.
28. Sealey JE, Catanzaro DF, Lavin TN et al. Specific prorenin/renin binding (ProBP). Identification and characterization of a novel membrane site. Am J Hypertens 1996;9:491-502.
29. Ichihara A, Hayashi M, Kaneshiro Y et al. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin. J Clin Invest 2004;114:1128-35.